James Pinkerton

1.5k total citations · 1 hit paper
13 papers, 908 citations indexed

About

James Pinkerton is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, James Pinkerton has authored 13 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in James Pinkerton's work include Asthma and respiratory diseases (12 papers), IL-33, ST2, and ILC Pathways (4 papers) and Pediatric health and respiratory diseases (3 papers). James Pinkerton is often cited by papers focused on Asthma and respiratory diseases (12 papers), IL-33, ST2, and ILC Pathways (4 papers) and Pediatric health and respiratory diseases (3 papers). James Pinkerton collaborates with scholars based in Australia, United Kingdom and Ireland. James Pinkerton's co-authors include Jay C. Horvat, Philip M. Hansbro, Richard Kim, Matthew A. Cooper, Peter G. Gibson, Malcolm R. Starkey, Jemma Mayall, Ama‐Tawiah Essilfie, Darryl A. Knight and Jeremy A. Hirota and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

James Pinkerton

13 papers receiving 902 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role for NLRP3 Inflammasome–mediated, IL-1β–Dependent Responses in Severe, Steroid-Resistant Asthma

2017 315 citations Richard Kim, James Pinkerton et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Pinkerton Australia	8	423	391	381	314	128	13	908
S. Létuvé France	16	459 1.1×	386 1.0×	439 1.2×	342 1.1×	93 0.7×	28	1.2k
Michelle L. Manni United States	18	295 0.7×	244 0.6×	342 0.9×	210 0.7×	71 0.6×	34	923
Jessica Ahern Australia	12	226 0.5×	249 0.6×	382 1.0×	423 1.3×	80 0.6×	14	906
Mahesh Raundhal United States	12	606 1.4×	206 0.5×	545 1.4×	262 0.8×	71 0.6×	15	1.0k
Yusheng Qiu United Kingdom	13	638 1.5×	143 0.4×	259 0.7×	722 2.3×	167 1.3×	18	1.1k
Taku Kodama United States	20	634 1.5×	161 0.4×	661 1.7×	252 0.8×	78 0.6×	28	1.2k
Keiko Kan‐o Japan	16	185 0.4×	146 0.4×	232 0.6×	254 0.8×	47 0.4×	42	685
Olaf Eickmeier Germany	17	218 0.5×	181 0.5×	171 0.4×	516 1.6×	50 0.4×	55	1.0k
Carina Gabriela Uasuf Italy	12	796 1.9×	126 0.3×	375 1.0×	477 1.5×	90 0.7×	28	1.4k
Susan Foley Canada	12	903 2.1×	138 0.4×	671 1.8×	445 1.4×	115 0.9×	18	1.4k

Countries citing papers authored by James Pinkerton

Since Specialization

Citations

This map shows the geographic impact of James Pinkerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Pinkerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Pinkerton more than expected).

Fields of papers citing papers by James Pinkerton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Pinkerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Pinkerton. The network helps show where James Pinkerton may publish in the future.

Co-authorship network of co-authors of James Pinkerton

This figure shows the co-authorship network connecting the top 25 collaborators of James Pinkerton. A scholar is included among the top collaborators of James Pinkerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Pinkerton. James Pinkerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pinkerton, James, Silvia Preite, Antonio Piras, et al.. (2024). PI3Kγδ inhibition suppresses key disease features in a rat model of asthma. Respiratory Research. 25(1). 175–175. 2 indexed citations

Pinkerton, James, Thomais Markou, Annika Borde, et al.. (2020). Profiling the impact of two JAK inhibitors in a pre-clinical model of allergic asthma. 3302–3302. 1 indexed citations

Pinkerton, James, Richard Kim, Nicole Armbruster, et al.. (2020). Human β‐defensin‐2 suppresses key features of asthma in murine models of allergic airways disease. Clinical & Experimental Allergy. 51(1). 120–131. 21 indexed citations

Pinkerton, James, Richard Kim, Alexandra C. Brown, et al.. (2019). IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma. PA3345–PA3345. 2 indexed citations

Kim, Richard, James Pinkerton, Ama‐Tawiah Essilfie, et al.. (2017). Role for NLRP3 Inflammasome–mediated, IL-1β–Dependent Responses in Severe, Steroid-Resistant Asthma. American Journal of Respiratory and Critical Care Medicine. 196(3). 283–297. 315 indexed citations breakdown →

Pinkerton, James, Richard Kim, Avril A. B. Robertson, et al.. (2017). Inflammasomes in the lung. Molecular Immunology. 86. 44–55. 131 indexed citations

Kim, Richard, Jay C. Horvat, James Pinkerton, et al.. (2016). MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2. Journal of Allergy and Clinical Immunology. 139(2). 519–532. 164 indexed citations

Kim, Richard, Rachel Neal, Chantal Donovan, et al.. (2016). Elucidating novel disease mechanisms in severe asthma. Clinical & Translational Immunology. 5(7). e91–e91. 26 indexed citations

Pinkerton, James, Richard Kim, Ama‐Tawiah Essilfie, et al.. (2016). Investigating antioxidant therapy for steroid-resistant asthma. PA570–PA570. 2 indexed citations

10.

Kim, Richard, James Pinkerton, Peter G. Gibson, et al.. (2015). Inflammasomes in COPD and neutrophilic asthma. Thorax. 70(12). 1199–1201. 107 indexed citations

11.

Essilfie, Ama‐Tawiah, Jay C. Horvat, Richard Kim, et al.. (2015). Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. Thorax. 70(5). 458–467. 104 indexed citations

12.

Singanayagam, Aran, Nicholas Glanville, Ross P. Walton, et al.. (2015). A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD. Clinical Science. 129(3). 245–258. 32 indexed citations

13.

Hansbro, Philip M., Richard Kim, James Pinkerton, et al.. (2015). MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying PI3K-mediated suppression of HDAC2 (HYP7P.262). The Journal of Immunology. 194(1_Supplement). 191.10–191.10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact